{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:50:16Z","timestamp":1773057016252,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.amjcard.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T14:23:26Z","timestamp":1529677406000},"page":"1017-1020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure"],"prefix":"10.1016","volume":"122","author":[{"given":"Shane","family":"Nanayakkara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Crannitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.06.009_bib0001","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.115.002481","article-title":"Chronic inotropic therapy in the current era: old wines with new pairings","volume":"8","author":"Pinney","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0002","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013\u00a0ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/american heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0003","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2015.12.030","article-title":"Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy","volume":"117","author":"Acharya","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0004","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCHEARTFAILURE.114.001778","article-title":"Clinical characteristics and outcomes of intravenous inotropic therapy in advanced heart failure","volume":"8","author":"Hashim","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0006","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IJGM.S62549","article-title":"Inotropes do not increase mortality in advanced heart failure","volume":"7","author":"Guglin","year":"2014","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0007","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.healun.2007.02.004","article-title":"Home inotropic therapy in children","volume":"26","author":"Berg","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0008","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9149(85)90145-6","article-title":"Acute dose range study of milrinone in congestive heart failure","volume":"55","author":"Kubo","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000176828","article-title":"Hemodynamic effects and pharmacokinetics of oral milrinone for short-term support in acute heart failure","volume":"86","author":"Seino","year":"1995","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0010","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ejhf.584","article-title":"Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial","volume":"18","author":"Adams","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0011","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure I. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.06.009_bib0012","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1093\/eurheartj\/ehp338","article-title":"Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials","volume":"30","author":"Metra","year":"2009","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918312451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918312451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:42:52Z","timestamp":1538070172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918312451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0002914918312451"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.009","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733766346.793551311","asserted-by":"object"}]},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}